The German Vaccine Commission has stated that the AstraZeneca COVID-19 vaccine should not be used in people over the age of 65 due to “insufficient data” on its effectiveness.
The Standing Committee on Vaccines has stated that the shot, which is being developed in conjunction with Oxford University, should only be used on people aged 18 to 64 “based on available data”.
“Currently, there are insufficient data to evaluate the effectiveness of the vaccine for people aged 65 and over,” said the group of scientific experts.
The recommendation follows the confusion earlier this week about the effectiveness of AstraZeneca in adults over 65 years of age.
Two German newspapers, citing government sources, said the shooting was found at 8% in the elderly – which the UK company said was “completely incorrect”, German broadcaster Deutsch Welle reported on Tuesday.
“In November, we published data in The Lancet showing that older adults had strong immune responses to the vaccine, with 100% of older adults generating peak-specific antibodies after the second dose,” said an AstraZeneca spokesman.
The astonishing statistics were also refuted by the German Ministry of Health, which suggested that the leaks mixed the figure of 8%.
“At first glance, it seems that two things were confused in the reports: About 8% of the subjects in the AstraZeneca efficacy study were between 56 and 69 years old and only 3 to 4% were over 70 years old,” A said a spokesman.
However, this does not deduce an effectiveness of only 8% in the elderly.
The European Medicines Agency is expected to decide whether to approve the AstraZeneca vaccine on Friday.
With Post threads